Frederick L. Ferris
Impact in
- Ophthalmology top 0.01%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Retinal and Optic Conditions
- Ocular Diseases and Behçet’s Syndrome
- Radiology, Nuclear Medicine and Imaging top 0.02%
- Retinal Imaging and Analysis
Papers in
- Ophthalmology 130
- Retinal Diseases and Treatments 118
- Retinal and Optic Conditions 15
- Glaucoma and retinal disorders 9
-
- Retinal Imaging and Analysis 35
- Retinopathy of Prematurity Studies 7
- Co-authors
- Emily Y. Chew (74 shared papers)Ian L. Bailey (3 shared papers)Aaron Kassoff (3 shared papers)George H. Bresnick (2 shared papers)Ronald Klein (6 shared papers)Roy W. Beck (20 shared papers)Neil M. Bressler (19 shared papers)Lloyd Paul Aiello (15 shared papers)
- Journals
- Ophthalmology (50 papers)Investigative Ophthalmology & Visual Science (25 papers)American Journal of Ophthalmology (16 papers)JAMA Ophthalmology (13 papers)Retina (12 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Frederick L. Ferris
187 papers receiving 25.7k citations
Frederick L. Ferris's Hit Papers
Peers
Comparison fields: 5 of 176
- Ophthalmology 17.2k
- Radiology, Nuclear Medicine and Imaging 7.4k
- Biochemistry 411
- Clinical Biochemistry 449
- Neurology 526
Countries citing papers authored by Frederick L. Ferris
This map shows the geographic impact of Frederick L. Ferris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick L. Ferris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick L. Ferris more than expected).
Fields of papers citing papers by Frederick L. Ferris
This network shows the impact of papers produced by Frederick L. Ferris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick L. Ferris. The network helps show where Frederick L. Ferris may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick L. Ferris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Complement Factor H Polymorphism in Age-Related Macular Degeneration Hit paper breakdown → | 2005 | 3287 |
| 2 | Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales Hit paper breakdown → | 2003 | 2762 |
| 3 | New Visual Acuity Charts for Clinical Research Hit paper breakdown → | 1982 | 1779 |
| 4 | Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration Hit paper breakdown → | 2012 | 1397 |
| 5 | Clinical Classification of Age-related Macular Degeneration Hit paper breakdown → | 2013 | 1338 |
| 6 | Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema Hit paper breakdown → | 2010 | 1077 |
| 7 | Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema Hit paper breakdown → | 2016 | 733 |
| 8 | Guidelines on Diabetic Eye Care Hit paper breakdown → | 2018 | 554 |
| 9 | Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration Hit paper breakdown → | 2016 | 553 |
| 10 | Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy Hit paper breakdown → | 2015 | 542 |
| 11 | A computerized method of visual acuity testing Hit paper breakdown → | 2003 | 494 |
| 12 | Diabetic Retinopathy Hit paper breakdown → | 2004 | 486 |
| 13 | SENILE MACULAR DEGENERATION: A CASE-CONTROL STUDY Hit paper breakdown → | 1983 | 468 |
| 14 | Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema Hit paper breakdown → | 2011 | 432 |
| 15 | Age-related macular degeneration Hit paper breakdown → | 2008 | 414 |
| 16 | 2003 | 294 | |
| 17 | 2012 | 290 | |
| 18 | 2012 | 268 | |
| 19 | Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy Hit paper breakdown → | 2018 | 266 |
| 20 | 1984 | 264 |
About Frederick L. Ferris
Frederick L. Ferris is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Epidemiology and Biochemistry, having authored 192 papers that have together received 26.6k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (118 papers), Retinal Imaging and Analysis (35 papers), Retinal and Optic Conditions (15 papers), Ophthalmology and Visual Impairment Studies (11 papers), Glaucoma and retinal disorders (9 papers), Connexins and lens biology (8 papers), Retinopathy of Prematurity Studies (7 papers) and Antioxidant Activity and Oxidative Stress (7 papers). The work is most often cited by research in Ophthalmology (17.2k citations), Radiology, Nuclear Medicine and Imaging (7.4k citations), Biochemistry (411 citations), Clinical Biochemistry (449 citations) and Neurology (526 citations). Frederick L. Ferris has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Emily Y. Chew, Ian L. Bailey, Aaron Kassoff, George H. Bresnick, Ronald Klein, Roy W. Beck, Neil M. Bressler, Lloyd Paul Aiello, Adam R. Glassman and John Paul SanGiovanni. Their work appears in journals such as Ophthalmology, Investigative Ophthalmology & Visual Science, American Journal of Ophthalmology, JAMA Ophthalmology and Retina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.